Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-43237
Mol Cancer January 13, 2011; 10 (1): 7.

Epigenetic reprogramming of breast cancer cells with oocyte extracts.

Allegrucci C , Rushton MD , Dixon JE , Sottile V , Shah M , Kumari R , Watson S , Alberio R , Johnson AD .


Abstract
BACKGROUND: Breast cancer is a disease characterised by both genetic and epigenetic alterations. Epigenetic silencing of tumour suppressor genes is an early event in breast carcinogenesis and reversion of gene silencing by epigenetic reprogramming can provide clues to the mechanisms responsible for tumour initiation and progression. In this study we apply the reprogramming capacity of oocytes to cancer cells in order to study breast oncogenesis. RESULTS: We show that breast cancer cells can be directly reprogrammed by amphibian oocyte extracts. The reprogramming effect, after six hours of treatment, in the absence of DNA replication, includes DNA demethylation and removal of repressive histone marks at the promoters of tumour suppressor genes; also, expression of the silenced genes is re-activated in response to treatment. This activity is specific to oocytes as it is not elicited by extracts from ovulated eggs, and is present at very limited levels in extracts from mouse embryonic stem cells. Epigenetic reprogramming in oocyte extracts results in reduction of cancer cell growth under anchorage independent conditions and a reduction in tumour growth in mouse xenografts. CONCLUSIONS: This study presents a new method to investigate tumour reversion by epigenetic reprogramming. After testing extracts from different sources, we found that axolotl oocyte extracts possess superior reprogramming ability, which reverses epigenetic silencing of tumour suppressor genes and tumorigenicity of breast cancer cells in a mouse xenograft model. Therefore this system can be extremely valuable for dissecting the mechanisms involved in tumour suppressor gene silencing and identifying molecular activities capable of arresting tumour growth. These applications can ultimately shed light on the contribution of epigenetic alterations in breast cancer and advance the development of epigenetic therapies.

PubMed ID: 21232089
PMC ID: PMC3034708
Article link: Mol Cancer
Grant support: [+]

Species referenced: Xenopus laevis
Genes referenced: actb actl6a ccnd2 cstb gas2 rarb
GO keywords: regulation of gene expression, epigenetic

Disease Ontology terms: breast cancer

Article Images: [+] show captions
References [+] :
Alberio, Differential nuclear remodeling of mammalian somatic cells by Xenopus laevis oocyte and egg cytoplasm. 2005, Pubmed, Xenbase